SI-BONE

Historical price data

SI-BONE's mission is to improve the quality of life for patients suffering from SI joint dysfunction through innovative, minimally invasive surgical solutions. The company has established itself as the market leader with its FDA-cleared iFuse Implant System, backed by a deep clinical evidence portfolio including multiple randomized controlled trials. Its strategy focuses on expanding physician training, penetrating the large, under-addressed market of chronic low back pain, and leveraging its platform into adjacent applications like spinopelvic fixation and pelvic trauma.

Proprietary triangular titanium implant platform (iFuse Technology®) designed for minimally invasive fusion and fixation of the sacroiliac joint, with extensions into spinopelvic and pelvic trauma applications.

SI-BONE is the market leader in MIS SI joint fusion, differentiated by its Level I clinical evidence and triangular implant design. It primarily competes against conservative pain management and, to a lesser extent, other device companies with inferior data. In adjacent markets (spinopelvic, trauma), it faces large, established orthopedic and spine corporations.